Blood-Brain Barrier 강 경 태 2013.12.06. Contents 1. BBB Fundamentals 2. Effects of Brain Penetration 3. Structure-BBB Penetration Relationships 4. Structure.

Slides:



Advertisements
Similar presentations
Pharmacological P-gp identification Since P-gp mediated drug efflux is a major hurdle in CNS drug discovery, it is important to identify P-gp substrates.
Advertisements

HLTH 340 Lecture A4 Toxicokinetic processes: Distribution (part-1)
Blood-Brain Barrier. CHEM E-1202 Blood-Brain Barrier (BBB) A physical barrier that controls the movement of chemicals f rom blood into the extracellular.
Assessment Statements H.3.1 Draw and label a diagram showing a transverse section of the ileum as seen under a light microscope. H.3.2 Explain the structural.
Peripheral inflammatory pain (λ-carrageenan injection) promotes localized paw edema and hyperalgesia Peripheral inflammatory pain reduces morphine efficacy.
Modern Tools for Drug Discovery NIMBUS Biotechnology Modern Tools for Drug Discovery
Administration and Absorption of Drugs. Factors that effect the action of a drug 1.Rate of accumulation at its site of action 2.Concentration of the drug.
Ionization and dissociation of drugs-1
Lipinski’s rule of five
VM 8314 Dr. Wilcke Drug Distribution. VM 8314 Dr. Wilcke  Vascular space =  Plasma/plasma water + (extracellular space)  Many RBC’s (intracellular.
DISTRIBUTION The body is a container in which a drug is distributed by blood (different flow to different organs) - but the body is not homogeneous. Factors.
Neurobiology course Group 7 Ivana Mizikova Salla Kangas Henri Urpilainen.
CEREBROSPINAL FLUID EXAMINATION Institute of Diagnostics Zhong Ning Institute of Diagnostics Zhong Ning
Pharmacokinetics Chapter 4.
Drug-Like Properties: Optimizing Pharmacokinetics and Safety During Drug Discovery Li Di and Edward H. Kerns ACS Short Course.
1 Chapter 9 Cerebrospinal Fluid Professor A. S. Alhomida Disclaimer The texts, tables, figures and images contained in this course presentation (BCH 376)
Drug Absorption Lesson 4. Drug T A Blood Brain CTZCTZ Organs & Tissues.
LECTURE DR ZAHOOR ALI SHAIKH 1. Plasma membrane is selectively permeable that means it allows some particles to pass while other can not pass. Things.
Chemical Basis of Life. Ionic Bonding
Pharmacology Department
MECHANISMS OF DRUG PERMEATION / TRANSPORT
Is the passage of drug from its site of administration to its site of action through cell membranes. Sites of Administration Sites of action Cell membrane.
Prof. Hanan Hagar Pharmacology Department. What student should know  Major body fluid compartments  Concept of compartments.  Apparent volume of distribution.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
Prof. Hanan Hagar Pharmacology Department.  Is the fraction of unchanged drug that enters systemic circulation after administration and becomes available.
Water and Solute Transport. Homeostasis Requires Exchange of Materials Transportation of solutes in solution –Movement between external and internal environments.
PHARMACOKINETICS CH. 4 Part 2. GETTING IN ABSORPTION Definition – the movement of a drug from the site of administration into the fluids of the body.
1 Pharmacology Pharmacokinetics –Absorption –Distribution –Biotransformation (metabolism) –Excretion Pharmacodynamics –Receptor binding –Signal transduction.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
Virtual Screening C371 Fall INTRODUCTION Virtual screening – Computational or in silico analog of biological screening –Score, rank, and/or filter.
BIOAVAILABILITY Time course of drug in the body: route of drug administration Oral vs IV injection Reasons for differences: completeness and rate of absorption.
Lipophilicity & Permeability 김연수. Chapter 5. Lipophilicity.
Pharmacology Department
Plasma Protein Binding
PHARMACOKINETICS Definition: quantitative study of drug absorption, distribution, metabolism, and excretion (ADME), and their mathematical relationship.
Pharmacology Department
Chapter 6. pKa & Chapter 7. Solubility
Chapt2student 2-1 Human Anatomy and Physiology I CHAPTER 2 Chemical Basis of Life.
Transporters Jun Min Jung. Overview Membrane transporters increase the influx and efflux of substrate compounds. Transporters are found in many tissues.
Chapter 61: Cerebral Blood Flow, CSF, And Brain Metabolism
Drug Absorption Lecture 4. Absorption n Movement from administration site into circulatory system n Complete when... l concentration at target equals.
김소연 Permeability OverviewPermeability FundamentalsPermeability EffectPermeability Structure Modification StrategiesProblem.
Part 2. Physicochemical Properties 1.Rules ( 양혜란 ) 2.Liphophilicity ( 백아름 ) 3.pKa ( 박숙진 ) 4.Solubility ( 전종수, 최영재 ) 5.Permeability ( 김소연, 강경태 )
Principles of Drug Action
Dan Greitz Dept. of Neuroradiology Karolinska University Hospital Stockholm, Sweden New view on the CSF circulation: CSF production and CSF absorption.
Do We Need to Optimize Protein Binding in Drug Discovery? NEDMDG Summary Meeting Xingrong Liu, Ph.D. Genentech.
Neuron : Supporting cells : –CNS : neuroglia (glia) –PNS : Schwann cells and satellite cells –Functions : physical support electrical insulation metabolic.
CHAPTER 4 L. VanValkenburg, RVT, BAS Pharmacokinetics.
Animal Circulatory Systems
Transporters Lee,Sang-Hwi. 9.1 Transporter Fundamentals Physicochemical properties lipophilicity hydrogen bonds M.W. Toxic xenobiotics (drugs)
ADME Dr Basma Damiri Toxicology In general, a toxicant should be absorbed in order to have an effect. True or false? Why? False Some toxicants.
By : Dr. Roshini Murugupillai
Julia Salas CS379a Aim of the Study To determine distinguishing features of orally administered drugs –Physical and structural features probed.
Pharmacology I Session One Pharmacological Principles.
Pharmacokienetic Principles (2): Distribution of Drugs
Lipinski’s rule of five
Basic Principles: PK By: Alaina Darby.
Transportation and Transformation of Xenobiotics
Medicinal chemistry Third stage Lecture 1
Pharmaceutics 2.
Pharmacokinetics: Drug Distribution and Drug Reservoirs
Recovery of Osmolarity in the Extracellular Fluid and the Brain during an Acute Hypo-osmotic Challenge Victoria Hunt with Dr. Qain-Quan Sun Department.
Virtual Screening.
Rules for Rapid Property Profiling from Structure
Pharmacokinetics: Drug Distribution and Drug Reservoirs
Cell Structure and Function
Introduction to Pharmacology
Pharmacokinetics/Pharmacodynamics
S. Aday, R. Cecchelli, D. Hallier-Vanuxeem, M.P. Dehouck, L. Ferreira 
Prodrug Approaches for CNS Delivery
Presentation transcript:

Blood-Brain Barrier 강 경 태

Contents 1. BBB Fundamentals 2. Effects of Brain Penetration 3. Structure-BBB Penetration Relationships 4. Structure Modification Strategies to Improve Brain Penetration

BBB is restrictive for some compounds owing to P-glycoprotein efflux, absence of paracelluar permeation, and limited pinocytosis. Brain exposure is assessed in terms of BBB permeability or brain/plasma partition. Brain exposure is enhanced by reducing H-bonds, molecular weight, P-glycoprotein efflux, metabolism, and plasma protein binding, or increasing Log P. Blood-Brain Barrier

Central nervous system(CNS) disorders are the second largest pharmaceutical therapeutic area. U.S pharmacy purchases September 2002 to August 2003 are shown $57,736 $53,610 $44,301 $27,107 $25,502

Blood-Brain Barrier

BBB Fundamentals The term BBB permeation is widely used in CNS discovery projects. BBB permeation is a major factor in brain penetration. that it is the sum of multiple mechanisms at the BBB. These depend on the compound properties and target location.

BBB Fundamentals The BBB is associated with the microcapillary blood vessels that run throughout the brain in close proximity to brain cells. These vessels naturally provide the nutrients and oxygen needed by the CNS cells and carry away waste.

BBB Permeation Mechanisms Mechanisms affecting BBB permeation The BBB forms a permeation barrier that is more limiting to compound penetration than are most other membrane barriers in the body. BBB endothelial cells tends to have significant negatively charged polarity head groups, which opposes acids.

Pgp Efflux Efflux is a major limitation to BBB permeation for some compounds. an important strategy for increasing brain exposure of these compounds is to reduce efflux by Pgp. Endothelial cells also express breast cancer resistance protein (BCRP) and multidrug resistance protein 1 (MRP1) through MRP6, which efflux some compounds. ER > 3 (high Pgp efflux) Pgp knockout mice also are used for verification of the in vitro conclusions. A survey of successful CNS drugs indicated ER 3 for 6%. BBB Permeation Mechanisms Efflux ratio(ER) = efflux / infflux

BBB Permeation Mechanisms Paracellular permeation Paracellular permeation is drastically limited in the BBB. because the endothelial cells form tight junctions. Pinocytosis Metabolism Pinocytosis in BBB endothelial cells is limited. Metabolism (phases I and II) has been observed in BBB endothelial cells. This structurally modifies compounds before they can reach brain tissue. The role of metabolism at the BBB likely is small.

Brain Distribution Mechanisms Several mechanisms limit the access of compounds to brain cells by affecting the distribution of compound to or within the brain Metabolic clearance Plasma protein binding Nonspecific binding to proteins and lipids in brain tissue Clearance of compound from the extracellular fluid (ECF) into the blood and cerebrospinal fluid (CSF)

Brain Distribution Mechanisms High hepatic clearance High hepatic clearance limits exposure of compounds to the brain.

Brain Distribution Mechanisms Plasma protein bindng Free unbound drug permeates the BBB. If the compound is highly bound to plasma protein, little free drug is available to penetrate into the brain tissue.

Brain Distribution Mechanisms bound drug can release in brain microvessel circulation in vivo much more than with in vitro assays.

Brain Distribution Mechanisms Compound in ECF is cleared into the blood and the CSF. If a compound has low BBB permeation, this clearance may limit the concentration in the ECF.

Brain-CSF Barrier The BCSFB is not considered an effective route for drug delivery to the brain Because, (1)the surface area of the BBB is 5,000-fold larger than the BCSFB (2)there is little mixing of the CSF components with the ECF (3)the CSF flows very fast away from the brain tissue toward the arachnoid villi (4) CSF is turned over every 5 hours. BBB > BCSFB 5,000-fold BCSFB : blood–cerebrospinal fluid barrier

Interpreting Data for Brain Penetration minimum guideline for CNS discovery projects A ratio of drug in brain to drug in plasma or blood. This value is often termed B/P; Log BB. yet some commercial CNS drugs have B/P < 0.1. B/P = concentration in the brain concentration in the plasma B/P > 0.3 penetrate poorly into the brain B/P < 0.1

Interpreting Data for Brain Penetration Kpfree = Cunbound Brain / Cunbound Plasma The term B/P is calculated from various data: AUC brain / AUC plasma Concentrationbrain / Concentrationplasma at a single time point or at Cmax Concentrationbrain / Concentrationplasma at steady state (also termed Kp)

Effects of Brain Penetration

Structure-BBB Penetration Relationships By Pardridge H-bond (total) <8~10 MW < 400~500 No acids By Sparklin H-bond donors < 2 H-bond acceptors < 6 By Clark and Lobell N + O < 6 PSA < 60~70 Å 2 Log D = 1~3 ClogP – (N+O) >0 BBB rule Hydrogen bonds (acceptors and donors) Lipophilicity Polar surface area (PSA) Molecular weight (MW) Acidity

Structure-BBB Penetration Relationships

75% 19% 6%

Structure Modification Strategies to Improve Brain Penetration Reduce P-glycoprotein efflux Reduce hydrogen bonds Increase lipophilicity Reduce molecular weight Replace carboxylic acid groups Add an intramolecular hydrogen bond Modify or select structures for affinity to uptake transporters

Reduce Hydrogen bonds Series of Steroids Reducing the total number of hydrogen bonds will increase BBB permeation, especially H-bond donors.

Reduce Hydrogen bonds Reduction of one hydrogen bond donor by blocking with a methyl group greatly increased brain penetration.

Increase Lipophilicity Increasing lipophilicity will increase BBB permeation. 10 fold100 fold

Reduce MW If groups on the structure can be removed without greatly impairing activity, then removing them can be beneficial. This reduces molecular size and improves permeation through lipid bilayer membranes.

Replace Carboxylic Acid Groups Elimination of an acidic group will increase BBB permeation.

Add an Intramolecular Hydrogen Bond An intramolecular hydrogen bond will increase BBB permeation. It reduces the total number of hydrogen bonds with water that must be broken for BBB permeation.

Modify or Select Structures for Affinity to Uptake Transporters LAT1 large neutral amino acid transporter enhances the brain uptake of l-dopa and gabapentin GLUT1 Glucose transporters on the luminal side of the BBB endothelial cells MCT1 monocarboxylic acids CAT1 CNT2 cationic amino acids nucleosides

2. Drug concentration is much lower in the blood than in the GI lumen. Pgp can be saturated in the GI but not at the BBB.